Axogen, Inc. — Director's Dealing 2011

Dec 21, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2011-12-19

Reporting Person: Zaderej Karen L. (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-12-19	Common Stock	M	3348	$0.27	Acquired	46397	Direct
2011-12-19	Common Stock	M	1398	$0.27	Acquired	47795	Direct
2011-12-19	Common Stock	M	16773	$0.27	Acquired	64568	Direct
2011-12-19	Common Stock	M	674	$0.27	Acquired	65242	Direct
2011-12-19	Common Stock	M	381	$0.27	Acquired	65623	Direct
2011-12-19	Common Stock	M	54167	$0.27	Acquired	119790	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-12-19	Employee Stock Option (right to buy)	$0.27	M	3348	Disposed	2016-06-07	Common Stock (3348)	Direct
2011-12-19	Employee Stock Option (right to buy)	$0.27	M	1398	Disposed	2017-04-27	common stock (1398)	Direct
2011-12-19	Employee Stock Option (right to buy)	$0.27	M	16773	Disposed	2017-12-06	common stock (16773)	Direct
2011-12-19	Employee Stock Option (right to buy)	$0.27	M	674	Disposed	2017-12-06	common stock (674)	Direct
2011-12-19	Employee Stock Option (right to buy)	$0.27	M	381	Disposed	2018-11-18	common stock (381)	Direct
2011-12-19	Employee Stock Option (right to buy)	$0.27	M	54167	Disposed	2020-06-09	common stock (54167)	Direct

Footnotes

F1: Acquired through exercise of vested portion of stock options.

F2: These options vest semi-annually over four years from the date of grant.

F3: All remaining option shares unvested.